{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 30530
    }
  },
  "results": [
    {
      "safetyreportversion": "2",
      "safetyreportid": "10004807",
      "primarysourcecountry": "RU",
      "occurcountry": "RU",
      "transmissiondateformat": "102",
      "transmissiondate": "20141212",
      "reporttype": "1",
      "serious": "1",
      "seriousnesshospitalization": "1",
      "receivedateformat": "102",
      "receivedate": "20140312",
      "receiptdateformat": "102",
      "receiptdate": "20140422",
      "fulfillexpeditecriteria": "1",
      "companynumb": "RU-VIIV HEALTHCARE LIMITED-B0975792A",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "GLAXOSMITHKLINE",
        "duplicatenumb": "RU-VIIV HEALTHCARE LIMITED-B0975792A"
      },
      "primarysource": {
        "reportercountry": "RU",
        "qualification": "5"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientsex": "2",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Hepatitis C",
            "reactionoutcome": "3"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Hepatic pain",
            "reactionoutcome": "3"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Dysgeusia",
            "reactionoutcome": "6"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "EPIVIR",
            "drugauthorizationnumb": "020564",
            "drugdosageform": "UNKNOWN",
            "drugadministrationroute": "065",
            "drugindication": "HIV INFECTION",
            "actiondrug": "4",
            "openfda": {
              "application_number": [
                "NDA020564",
                "NDA020596"
              ],
              "brand_name": [
                "EPIVIR"
              ],
              "generic_name": [
                "LAMIVUDINE"
              ],
              "manufacturer_name": [
                "ViiV Healthcare Company"
              ],
              "product_ndc": [
                "49702-203",
                "49702-204",
                "49702-205"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "LAMIVUDINE"
              ],
              "rxcui": [
                "152931",
                "152932",
                "199147",
                "199148",
                "349491",
                "352230"
              ],
              "spl_id": [
                "3d326658-e562-4d27-a0ad-ca2017db2e49"
              ],
              "spl_set_id": [
                "89226149-47fa-4f7d-bb1f-1aa7034486b8"
              ],
              "package_ndc": [
                "49702-203-18",
                "49702-204-13",
                "49702-205-48"
              ],
              "nui": [
                "N0000175656",
                "N0000175462",
                "N0000009947"
              ],
              "pharm_class_epc": [
                "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
                "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
              ],
              "pharm_class_moa": [
                "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
              ],
              "unii": [
                "2T8Q726O95"
              ]
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "VIDEX",
            "drugdosageform": "UNKNOWN",
            "drugadministrationroute": "065",
            "drugindication": "HIV INFECTION",
            "actiondrug": "4"
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "ATAZANAVIR",
            "drugdosageform": "UNKNOWN",
            "drugadministrationroute": "065",
            "drugindication": "HIV INFECTION",
            "actiondrug": "4",
            "openfda": {
              "application_number": [
                "NDA021567",
                "NDA206352",
                "ANDA212278",
                "ANDA212579",
                "ANDA204806"
              ],
              "brand_name": [
                "REYATAZ",
                "ATAZANAVIR",
                "ATAZANAVIR SULFATE"
              ],
              "generic_name": [
                "ATAZANAVIR"
              ],
              "manufacturer_name": [
                "E.R. Squibb & Sons, L.L.C.",
                "Camber Pharmaceuticals, Inc.",
                "Laurus Labs Limited",
                "Aurobindo Pharma Limited"
              ],
              "product_ndc": [
                "0003-3622",
                "0003-3624",
                "0003-3631",
                "0003-3638",
                "31722-653",
                "31722-654",
                "31722-655",
                "42385-920",
                "42385-921",
                "42385-922",
                "65862-710",
                "65862-711",
                "65862-712",
                "65862-713"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "ATAZANAVIR SULFATE"
              ],
              "rxcui": [
                "402093",
                "402094",
                "402246",
                "402247",
                "664741",
                "664743",
                "1598985",
                "1598989",
                "402245"
              ],
              "spl_id": [
                "510c2d51-4943-401c-a008-ea22f61c6938",
                "30891c38-5d64-7df7-e063-6394a90ae762",
                "0e18774c-a32c-4961-9684-f5c6ffce64a1",
                "8f8c56e0-40ee-4643-88f7-d3571ff5a409"
              ],
              "spl_set_id": [
                "165cff62-b284-4a27-a65d-9ec8a5bfcdd8",
                "8a0c609f-e296-4925-a35c-e93a04467655",
                "c98e40ec-8a2c-4f19-b1c3-c82f708c2490",
                "7fbea274-d6b5-4faa-bbf0-05fefab42114"
              ],
              "package_ndc": [
                "0003-3624-12",
                "0003-3631-12",
                "0003-3622-12",
                "0003-3638-10",
                "31722-653-60",
                "31722-653-10",
                "31722-653-31",
                "31722-654-60",
                "31722-654-10",
                "31722-654-31",
                "31722-655-30",
                "31722-655-05",
                "31722-655-31",
                "42385-920-60",
                "42385-920-06",
                "42385-920-48",
                "42385-921-60",
                "42385-921-06",
                "42385-921-48",
                "42385-922-30",
                "42385-922-06",
                "42385-922-37",
                "65862-710-60",
                "65862-710-05",
                "65862-710-10",
                "65862-710-03",
                "65862-711-60",
                "65862-711-18",
                "65862-711-05",
                "65862-711-10",
                "65862-711-03",
                "65862-712-60",
                "65862-712-18",
                "65862-712-05",
                "65862-712-10",
                "65862-712-03",
                "65862-713-30",
                "65862-713-90",
                "65862-713-05",
                "65862-713-10",
                "65862-713-03"
              ],
              "unii": [
                "4MT4VIE29P"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "URSODEOXYCHOLIC ACID",
            "drugdosagetext": "4TAB PER DAY",
            "drugdosageform": "TABLET",
            "actiondrug": "4"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "B VITAMINS",
            "actiondrug": "5"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "HERBAL MEDICINE",
            "actiondrug": "5"
          }
        ]
      }
    }
  ]
}